Cart (0 Items)
Your cart is currently empty.
View ProductsTabalumab Biosimilar – Anti-TNFSF13B, CD257 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Tabalumab Biosimilar - Anti-TNFSF13B, CD257 mAb - Research Grade |
|---|---|
| Source | CAS 1143503-67-6 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Tabalumab,LY2127399,TNFSF13B, CD257,anti-TNFSF13B, CD257 |
| Reference | PX-TA1275 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Tabalumab Biosimilar - Anti-TNFSF13B/CD257 mAb - Research Grade
General information on Anti-TNFSF13B/CD257[Homo sapiens] (Tabalumab) Monoclonal Antibody
Tabalumab has been investigated for the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus.
Related products
Antigen
CD257 / BAFF / TNFSF13B, C-His, recombinant protein
PX-P5600 385€
Antigen
CD257 Recombinant Protein
PX-P4112 406€
SIL
Reviews
Il n’y a pas encore d’avis.